The local station reported that Infinity Diagnostic Laboratory had a sign in its window Dec. 4 advertising “rapid 10-minute testing” to detect active COVID-19 infections or antibodies.
While it’s unclear what type of testing technology the lab was using, a Dec. 4 statement from the FBI’s office in Newark, N.J., urged anyone who received a finger prick blood test at the lab to contact the bureau. These types of tests should only be used for antibody testing, not to diagnose active virus cases, according to the FDA. One customer also said the lab did not accept credit card payment — just cash or electronic payments through Venmo.
The rapid testing sign was taken down Dec. 5, a day after the FBI raided the facility. The lab did not immediately respond to NBC10 Philadelphia‘s request for comment.
More articles on public health:
Number of COVID-19 hospitalizations, state by state: Dec. 7
5 states with most flu activity, per CDC’s Fluview report
‘A physician’s nightmare’: New Mexico hospitals likely to get OK to ration care
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
